Regeneron Pharmaceuticals Chooses Veeva Vault CRM for Global Operations

In a significant move aimed at improving its operational capabilities, Regeneron Pharmaceuticals has adopted Veeva Vault CRM across its global operations. The announcement, made by Veeva Systems (NYSE: VEEV), highlights the company's commitment to leveraging advanced technology for better business outcomes in the biopharmaceutical sector.

The Veeva Vault CRM platform is designed specifically for the life sciences industry. Using this innovative solution, Regeneron intends to harness artificial intelligence to enhance the quality and availability of commercial data derived from its field interactions. By doing so, Regeneron aims to uncover hidden barriers that might prevent the adoption of critical treatments and to ensure that medications reach eligible patients more effectively.

Ryan Steinberger, Regeneron's Executive Vice President and Chief Digital & Technology Officer, expressed enthusiasm about the partnership, stating that the adoption of Vault CRM will empower their commercial teams by providing them with a more connected platform. This move is expected to expedite access to vital information that supports effective decision-making.

Veeva's President of Commercial Strategy, Matt Farrell, commented on the strategic alliance, emphasizing that Regeneron's focus on making scientific advancements available to those in need aligns perfectly with Veeva’s vision of supporting life-changing pharmaceuticals with cutting-edge technology. He noted that the integration of Vault CRM positions Regeneron to continue its vital work in developing essential medicines.

Vault CRM is a part of the comprehensive Vault CRM Suite, which serves as a technological foundation for executing commercial strategies. The platform's integrated field visit reporting feature transforms every interaction into commercial evidence, enabling the collection of valuable insights that previously would have been lost due to compliance constraints and dropdown menu limitations.

Veeva Systems specializes in providing cloud-based solutions tailored for the life sciences sector, comprising a range of applications, data, and consulting services designed to drive innovation and customer success. With more than 1,500 clients, including major biopharmaceutical corporations and emerging biotech firms, Veeva maintains a strong commitment to balancing the interests of all stakeholders, including customers, employees, shareholders, and the industries it serves.

As Veeva continues to revolutionize the pharmaceutical landscape with its technology solutions, the collaboration with Regeneron sets a new precedent for the use of CRM systems in the biopharmaceutical space. Regeneron's proactive approach to utilizing CRM technology underscores the importance of data-driven decision-making in enhancing patient access to life-saving treatments.

In summary, the adoption of Veeva Vault CRM by Regeneron Pharmaceuticals marks a significant step forward in leveraging tech solutions to optimize commercial operations in the life sciences sector. With aspirations of not only streamlining processes but also improving health outcomes, Regeneron is well-positioned to enhance its role in the global healthcare system. This strategic move is expected to result in refined tactics that ultimately bring new medicines to the patients who need them the most.

For more information on Veeva's offerings, visit veeva.com.